Moreover, existing research has suggested that the abnormal expression of survivin in tumor cells is regulated by a variety of factors, including microRNA (miRNA), receptor tyrosine kinase (RTK), and their downstream signaling pathways (e.g., MAPK, PI3K/AKT, signal transducer, TAT3, and other pathways)40. The gene discussed is BIRC5; the disease is neoplasm.